Latest News & Features
Big Pharma
German pharmaceutical company Boehringer Ingelheim has entered into a second licence and collaboration agreement with Danish biotech company Gubra for the development of an obesity treatment. 30 May 2019
Americas
US biotechnology company Celgene has taken legal action against the registrant of a domain name which allegedly infringes Celgene’s trademarks. 30 May 2019
Europe
Biopharmaceutical company Sensorion has entered into a research collaboration with French research body Institut Pasteur. 29 May 2019
Biotechnology
A subsidiary of China-based genome sequencing company BGI has filed a patent infringement suit against a US competitor. 29 May 2019
Big Pharma
GSK has entered into a settlement agreement with California-based Laclede, ending a trademark infringement dispute between the pair. 28 May 2019
Biotechnology
The US Patent and Trademark Office has issued a new CRISPR/Cas9 patent to the University of California, the University of Vienna and microbiologist Emmanuelle Charpentier. 28 May 2019
Big Pharma
Four pharmaceutical companies allegedly agreed not to compete for the supply of an anti-nausea tablet to the National Health Service, according to objections filed by the UK Competition and Markets Authority. 24 May 2019
Big Pharma
The number of ‘pay-for-delay’ patent settlements reached in fiscal year 2016 represented a “considerable increase” from the previous year, according to a Federal Trade Commission report released yesterday, May 23, though there has been a considerable reduction in the most problematic settlements since 2013. 24 May 2019
Americas
Eli Lilly has released a generic insulin injection at half of the list price of its identical branded medicine to the US market. 23 May 2019
Big Pharma
Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is being sued for “unlawfully” delaying generic competition to Zytiga, its branded cancer medication. 23 May 2019